Over the past years, Chameleon Pharma Consulting has been a speaker in several European Pharma Events focusing on Consumer Health, OTC and Rx areas. We are engaged with important and complex issues in a Healthcare Consulting in the Emerging Markets.
7th European Pharma Licensing Symposium in Prague
The last conference we spoke at was the 7th European Pharma Licensing Symposium, held on September 23rd and 24th 2014 in Prague, Czech Republic. As a major Pharma event, the symposium attracted Pharma leaders from three continents.
The president of our company, Mr. Reiner Christensen, has been honoured to speak and share his experience and insights on the topic of “Are All the Emerging Markets Paying Their Way?” He pointed out the significant role of Emerging Markets in the Consumer Health, Rx and OTC fields. While BRIC countries are the most appealing markets for the Healthcare industry, Rx imported products struggle to compete with local companies and face immense pressure. On the other hand, some other Pharma Emerging Markets show a dynamic development of Healthcare industry and demand for Consumer Health, OTC and Rx products.
Featured image at the top: Photo by Maksym Harbar on Unsplash
Feedback Form
Related Posts
The Vietnamese consumer health and drug sales channel: opportunities for international companies
Get The Important Insights!The medicine sales network in Vietnam is shaped by the complementarity between public and private entities. The prior is...
The landscape of OTC and Rx drug sales networks in Thailand
Get The Important Insights! The self-medication and pharma Thai market is strongly influenced by the structure of its sales networks. The two...
The Shift of the Homeopathic and Phyto Healthcare Market from Europe to LATAM and Asia
Get The Important Insights!The global homeopathic market reached a valuation of 4,6 billion USD in 2020, representing less than 1% of the global...